Mehta et al., 2016 - Google Patents
Acute myocardial infarction in women: a scientific statement from the American Heart AssociationMehta et al., 2016
View HTML- Document ID
- 10928750193513854039
- Author
- Mehta L
- Beckie T
- DeVon H
- Grines C
- Krumholz H
- Johnson M
- Lindley K
- Vaccarino V
- Wang T
- Watson K
- Wenger N
- Publication year
- Publication venue
- Circulation
External Links
Snippet
Cardiovascular disease is the leading cause of mortality in American women. Since 1984, the annual cardiovascular disease mortality rate has remained greater for women than men; however, over the last decade, there have been marked reductions in cardiovascular …
- 206010000891 Acute myocardial infarction 0 title abstract description 243
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mehta et al. | Acute myocardial infarction in women: a scientific statement from the American Heart Association | |
Saw et al. | Spontaneous coronary artery dissection: clinical outcomes and risk of recurrence | |
Garcia et al. | Cardiovascular disease in women: clinical perspectives | |
Udell et al. | Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization | |
Garg et al. | Prediction of 1-year clinical outcomes using the SYNTAX score in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a substudy of the STRATEGY (single high-dose bolus tirofiban and sirolimus-eluting stent versus abciximab and bare-metal stent in acute myocardial infarction) and MULTISTRATEGY (multicenter evaluation of single high-dose bolus tirofiban versus abciximab with sirolimus-eluting stent or bare-metal stent in acute myocardial infarction study) trials | |
Wenger | Coronary heart disease: the female heart is vulnerable | |
Newby et al. | ACCF 2012 expert consensus document on practical clinical considerations in the interpretation of troponin elevations: a report of the American College of Cardiology Foundation task force on Clinical Expert Consensus Documents | |
Writing Committee Members* et al. | 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions | |
Loria et al. | Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes | |
O'Connor et al. | Part 10: acute coronary syndromes: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care | |
Ruiz-Nodar et al. | Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation: implications for bleeding risk and prognosis | |
Varghese et al. | Non-ST elevation acute coronary syndrome in women and the elderly: recent updates and stones still left unturned | |
Ben-Gal et al. | Surgical versus percutaneous revascularization for multivessel disease in patients with acute coronary syndromes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial | |
Poli et al. | Epidemiology, diagnosis, and management of atrial fibrillation in women | |
Pilmore | Cardiac assessment for renal transplantation | |
Weihs et al. | Stress-induced cardiomyopathy (Tako-Tsubo syndrome) in Austria | |
Rosen et al. | Sex-specific disparities in risk factors for coronary heart disease | |
Frederiksen et al. | The bidirectional association between atrial fibrillation and myocardial infarction | |
Hafiz et al. | Contemporary Clinical Outcomes of Primary Percutaneous Coronary Intervention in Elderly versus Younger Patients Presenting with Acute ST‐Segment Elevation Myocardial Infarction | |
Alberts et al. | Risk factors and outcomes for patients with vascular disease and serious bleeding events | |
Gheorghiade et al. | Anticoagulation in heart failure: current status and future direction | |
Jia et al. | The CHA2DS2-VASc score: Not as simple as it seems | |
Yan et al. | Effects of nurse-led multidisciplinary team management on cardiovascular hospitalization and quality of life in patients with atrial fibrillation: randomized controlled trial | |
Topol | A guide to therapeutic decision-making in patients with non–ST-segment elevation acute coronary syndromes | |
Segev et al. | Contemporary use and outcome of percutaneous coronary interventions in patients with acute coronary syndromes: insights from the 2010 ACSIS and ACSIS-PCI surveys |